116 related articles for article (PubMed ID: 36356894)
1. Effect of histone deacetylase 8 gene deletion on breast cancer cellular mechanism in vitro and in vivo study.
Rahmani G; Moloudi MR; Amini R; Rahimi K; Fathi F; Abdi M; Najafi R
Life Sci; 2022 Dec; 311(Pt A):121156. PubMed ID: 36356894
[TBL] [Abstract][Full Text] [Related]
2. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals.
An P; Li J; Lu L; Wu Y; Ling Y; Du J; Chen Z; Wang H
Eur J Pharmacol; 2019 Feb; 845():16-23. PubMed ID: 30582912
[TBL] [Abstract][Full Text] [Related]
4. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
5. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
[TBL] [Abstract][Full Text] [Related]
6. Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis.
Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yegane S; Elyasi A; Darvishi N; Hosseini V; Abdi M
Iran Biomed J; 2020 Sep; 24(5):288-94. PubMed ID: 32429642
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
[TBL] [Abstract][Full Text] [Related]
8. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
9. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Hsieh CL; Ma HP; Su CM; Chang YJ; Hung WY; Ho YS; Huang WJ; Lin RK
Life Sci; 2016 Apr; 151():7-14. PubMed ID: 26926079
[TBL] [Abstract][Full Text] [Related]
10. Discovery of highly potent HDAC8 PROTACs with anti-tumor activity.
Zhao C; Chen D; Suo F; Setroikromo R; Quax WJ; Dekker FJ
Bioorg Chem; 2023 Jul; 136():106546. PubMed ID: 37098288
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.
Lehmann M; Hoffmann MJ; Koch A; Ulrich SM; Schulz WA; Niegisch G
J Exp Clin Cancer Res; 2014 Jul; 33(1):59. PubMed ID: 25011684
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma.
Song S; Wang Y; Xu P; Yang R; Ma Z; Liang S; Zhang G
Int J Oncol; 2015 Nov; 47(5):1819-28. PubMed ID: 26412386
[TBL] [Abstract][Full Text] [Related]
14. Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells.
Pidugu VR; Yarla NS; Bishayee A; Kalle AM; Satya AK
Apoptosis; 2017 Nov; 22(11):1394-1403. PubMed ID: 28840369
[TBL] [Abstract][Full Text] [Related]
15.
Yang Y; Li M; Zhou X; Wang W; Shao Y; Yao J; Wang X
Ann Clin Lab Sci; 2022 May; 52(3):439-451. PubMed ID: 35777798
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.
Hu E; Chen Z; Fredrickson T; Zhu Y; Kirkpatrick R; Zhang GF; Johanson K; Sung CM; Liu R; Winkler J
J Biol Chem; 2000 May; 275(20):15254-64. PubMed ID: 10748112
[TBL] [Abstract][Full Text] [Related]
17. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
18. HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals.
An P; Chen F; Li Z; Ling Y; Peng Y; Zhang H; Li J; Chen Z; Wang H
Oncogene; 2020 Jun; 39(26):4956-4969. PubMed ID: 32499521
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma.
Ahn MY; Yoon JH
Oncol Rep; 2017 Jan; 37(1):540-546. PubMed ID: 28004115
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of histone deacetylase-8 in human breast cancer.
Rahmani G; Sameri S; Abbasi N; Abdi M; Najafi R
Pathol Res Pract; 2021 Apr; 220():153396. PubMed ID: 33691240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
